The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression

EMBO Reports

Volumn 6, Issue 3, 2005, Pages 268-274

  Cayuela, María Luisa ^a   Flores, Juana M ^b   Blasco, María A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cancer; Mouse models; Terc; Tert; Wound healing

Indexed keywords

PROTEIN TERC; RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CARCINOGENESIS; CHROMOSOME SIZE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; MOUSE; MOUSE STRAIN; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN TARGETING; TELOMERE; TUMOR GROWTH; TUMOR PROMOTION; WILD TYPE; WOUND HEALING;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; DNA-BINDING PROTEINS; GENE DELETION; IN SITU HYBRIDIZATION, FLUORESCENCE; KERATINOCYTES; MICE; MICE, KNOCKOUT; MUTATION; NEOPLASMS; PROTEIN SUBUNITS; RNA; SKIN NEOPLASMS; TELOMERASE; TETRADECANOYLPHORBOL ACETATE; WOUND HEALING;

EID: 16844382627     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.7400359     Document Type: Article

References (18)

1. Artandi SE et al (2002) Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA 99: 8191-8196
2. Balmain A, Ramsden M, Bowden GT, Smith J (1984) Activation of the mouse Harvey-ras gene in chemically induced benign skin papillomas. Nature 307: 658-660
3. Blasco MA (2002) Telomerase beyond telomeres. Nat Cancer Rev 2: 627-632
4. Blasco MA, Rizen M, Greider CW, Hanahan D (1996) Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 12: 200-204
5. Blasco MA et al (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34
6. Broccoli D, Codley LA, Donehower LA, Varmus HE, de Lange T (1996) Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol Cell Biol 16: 3765-3772
7. Canela A, Martín-Caballero J, Flores JM, Blasco MA (2004) Constitutive expression of Tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice. Mol Cell Biol 24: 4275-4293
8. Chin L et al (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97: 527-538
9. Espejel S et al (2004) Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86 or DNA-PKcs. J Cell Biol 167: 627-638
10. González-Suárez E, Samper E, Flores JM, Blasco MA (2000) Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 26: 114-117
11. González-Suarez E et al (2001) Increased epidermal tumors and increased skin, wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 20: 2619-2630
12. Goytisolo FA, Blasco MA (2002) Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene 21: 584-591
13. Greenberg RA et al (1999) Short dysfunctional telomeres impair tumorigenesis in the INK4a(δ2/3) cancer-prone mouse. Cell 97: 515-525
14. Smith LL, Coller HA, Roberts JM (2003) Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5: 474-479
15. Stewart SA et al (2003) Telomerase contributes to tumorigenesis by a e telomere length-independent mechanism. Proc Natl Acad Sci USA 99: 12606-12611
16. Theunissen JU et al (2003) Checkpoint failure and chromosomal instability without lymphomagenesis in Mre11 (ATLD1/ATLD1) mice. Mol Cell 12: 1511-1523
17. Wong KK et al (2003) Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421: 643-648
18. Yokoi S et al (2003) TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small lung cancers. Clin Cancer Res 9: 4705-4713